Antibody Analytics

The company operates as a preclinical contract research organisation (CRO) specializing in immunology and biotherapeutic development. It provides drug development services, including assay development, primary immune cell-based functional assays, and pre-IND testing for small molecules, large molecules, and advanced therapies. The firm serves biotechnology and pharmaceutical companies globally, supporting projects from early discovery through to clinical phases.